Ifakara science director on promising new malaria vaccine - AZAM MEDIA

On July 10, 2024, Dr. Ally Olotu, Ifakara Health Institute’s Director of Science, spoke with AZAM Media on its flagship news channel - UTV about the new malaria vaccine "RH5.1/Matrix-M," which has shown promise in early trials. The RH5.1/Matrix-M malaria vaccine demonstrated safety and effectiveness in early trials conducted at the Ifakara Clinical Trials Facility in Bagamoyo, Tanzania. This study was a collaboration between scientists from the University of Oxford, Ifakara Health Institute, the National Institutes of Health (USA), KEMRI-Wellcome Trust Research Programme (Kenya), Muhimbili National Hospital (Tanzania), and Novavax AB (Sweden), involving healthy adults and young children. VIDEO: Courtesy of AZAM MEDIA